James R. McNab, Director at TITAN PHARMACEUTICALS INC (TTNP), bought 200,000 shares at $0.25 ($50K) on 2018-09-21, disclosed to the SEC on 2018-09-25.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| CRIS | SELL | 2017-04-27 | $571K | — | Filing → |
| CRIS | SELL | 2017-04-27 | $618K | — | Filing → |
| CRIS | SELL | 2017-04-24 | $286K | — | Filing → |